Search - tctmd.com

Displaying 401 - 420 of 808

Sort: Relevancy | Date

Presentation TVT 2019

Technology Description, Clinical Data and Plans for the US Pivotal Trial

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Illustrative Cases

Presenter: Markus Kasel

June 13, 2019

Presentation TVT 2019

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Presenter: Dhaval Kolte

June 13, 2019

Presentation TVT 2019

Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Mao Chen

June 13, 2019

Presentation TVT 2019

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Does Surgical Risk Still Matter When Evaluating for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

The LOTUS Edge TAVR System: Clinical Trial Updates

Presenter: Chris Meduri

June 13, 2019

Presentation TVT 2019

Treatment of Severe Pulmonary Insufficiency in a Patient With Tetralogy of Fallot and Left Pulmonary Artery Stenosis With an Edwards Sapien3 Valve

Presenter: Isla McClelland

June 13, 2019

Presentation TVT 2019

Percutaneous Closure of an Acquired Aortic-Left Atrial Fistula

Presenter: Daniel Feldman

June 13, 2019

Presentation TVT 2019

Design Characteristics, Clinical Data, and Future Vision

Presenter: Alexandre Abizaid

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Helge Möllmann

June 13, 2019

Presentation TVT 2019

Design Characteristics, Clinical Data, and Future Vision

Presenter: Gregory Fontana

June 13, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Helge Möllmann

June 13, 2019

Presentation TVT 2019

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Presenter: Josep Rodés-Cabau

June 13, 2019

Presentation TVT 2019

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Presenter: Tamim Nazif

June 13, 2019

Advertisement

Technology Description, Clinical Data and Plans for the US Pivotal Trial

Illustrative Cases

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

2 Illustrative Cases – A Case-Based Discussion

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Better for Bicuspids and Dry Leaflet Technology

2 Illustrative Cases – A Case-Based Discussion

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Does Surgical Risk Still Matter When Evaluating for TAVR?

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

The LOTUS Edge TAVR System: Clinical Trial Updates

Treatment of Severe Pulmonary Insufficiency in a Patient With Tetralogy of Fallot and Left Pulmonary Artery Stenosis With an Edwards Sapien3 Valve

Percutaneous Closure of an Acquired Aortic-Left Atrial Fistula

Design Characteristics, Clinical Data, and Future Vision

2 Illustrative Cases – A Case-Based Discussion

Design Characteristics, Clinical Data, and Future Vision

2 Illustrative Cases – A Case-Based Discussion

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content